Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-26-324455
Filing Date
2026-07-30
Accepted
2026-07-29 20:26:22
Documents
22
Effectiveness Date
2026-07-30

Document Format Files

Seq Description Document Type Size
1 S-3ASR vktx-20260730.htm S-3ASR 898883
2 EX-4.2 vktx-ex4_2.htm EX-4.2 606211
3 EX-5.1 vktx-ex5_1.htm EX-5.1 66261
4 EX-23.1 vktx-ex23_1.htm EX-23.1 5154
5 EX-23.2 vktx-ex23_2.htm EX-23.2 6256
6 EX-FILING FEES vktx_exfilingfees.htm   iXBRL EX-FILING FEES 215681
7 GRAPHIC img75195117_0.jpg GRAPHIC 11923
8 GRAPHIC img75195117_1.jpg GRAPHIC 11923
9 GRAPHIC img75195117_2.jpg GRAPHIC 11923
10 GRAPHIC img246856755_0.jpg GRAPHIC 28888
11 GRAPHIC img246856755_1.jpg GRAPHIC 11290
12 GRAPHIC gfx141551186_0.gif GRAPHIC 724
  Complete submission text file 0001193125-26-324455.txt   2161995

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT vktx_exfilingfees_htm.xml XML 49325
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-297820 | Film No.: 261219778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)